Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 29.8926.6019.6619.3818.62

What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS is 29.89 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202529.89
Mar202426.60
Mar202319.66
Mar202219.38
Mar202118.62

How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 29.89
12.37
Mar2024 26.6
35.30
Mar2023 19.66
1.44
Mar2022 19.38
4.08
Mar2021 18.62 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹121,130.3 Cr -1.3% 0.8% 11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr -1.1% 1.9% -8.5% Stock Analytics
DIVIS LABORATORIES ₹176,708.0 Cr 3.5% 18.2% 15.4% Stock Analytics
CIPLA ₹121,525.0 Cr -2.6% -0.9% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,596.0 Cr 0.2% -3.5% -5.8% Stock Analytics
MANKIND PHARMA ₹93,419.6 Cr -5.6% -5.8% -11.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.3%

0.8%

11.7%

SENSEX

-1.4%

1.7%

4.8%


You may also like the below Video Courses